BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35917517)

  • 1. CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization.
    Hong X; Li Q; Li J; Chen K; He Q; Zhao Y; Liang Y; Zhao Y; Qiao H; Liu N; Ma J; Li Y
    Clin Cancer Res; 2022 Oct; 28(20):4521-4535. PubMed ID: 35917517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1.
    Hong X; Liu N; Liang Y; He Q; Yang X; Lei Y; Zhang P; Zhao Y; He S; Wang Y; Li J; Li Q; Ma J; Li Y
    Mol Cancer; 2020 Feb; 19(1):33. PubMed ID: 32061262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
    Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
    BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA SET domain protein 3 promotes nasopharyngeal carcinoma proliferation, cisplatin resistance, and protein kinase B / mammalian target of rapamycin pathway activation by modulating microRNA-147a expression.
    Deng G; Wang F; Song Y
    Bioengineered; 2022 Mar; 13(3):5843-5854. PubMed ID: 35196205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-Induced Senescence Reprogramming Promotes Nasopharyngeal Carcinoma Metastasis by circRNA-Mediated PKR Activation.
    Li Q; Zhao YH; Xu C; Liang YL; Zhao Y; He QM; Li JY; Chen KL; Qiao H; Liu N; Ma J; Chen L; Li YQ
    Adv Sci (Weinh); 2023 Mar; 10(8):e2205668. PubMed ID: 36683218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA EPB41L4A-AS2 represses Nasopharyngeal Carcinoma Metastasis by binding to YBX1 in the Nucleus and Sponging MiR-107 in the Cytoplasm.
    Du M; Hu X; Jiang X; Yin L; Chen J; Wen J; Fan Y; Peng F; Qian L; Wu J; He X
    Int J Biol Sci; 2021; 17(8):1963-1978. PubMed ID: 34131399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β-catenin axis.
    Shi X; Hu Z; Bai S; Zong C; Xue H; Li Y; Li F; Chen L; Xuan J; Xia Y; Wei L; Shen F; Wang K
    J Gene Med; 2024 May; 26(5):e3689. PubMed ID: 38676365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.
    Gao W; Li JZ; Chen SQ; Chu CY; Chan JY; Wong TS
    Cancer Med; 2017 Feb; 6(2):439-451. PubMed ID: 28083995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B.
    Zhao Y; Wang P; Wu Q
    Mol Cell Probes; 2020 Oct; 53():101597. PubMed ID: 32407879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma.
    Liu L; Deng P; Liu S; Hong JH; Xiao R; Guan P; Wang Y; Wang P; Gao J; Chen J; Sun Y; Chen J; Mai HQ; Tan J
    Cell Death Dis; 2023 Aug; 14(8):513. PubMed ID: 37563118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway.
    Li T; Li Y
    Immunobiology; 2023 Mar; 228(2):152324. PubMed ID: 36608594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16/TOP2A axis.
    Zhang B; Li J; Wang Y; Liu X; Yang X; Liao Z; Deng S; Deng Y; Zhou Z; Tian Y; Wei W; Meng J; Hu Y; Wan C; Zhang Z; Huang F; Wen L; Wu B; Sun Y; Li Y; Yang K
    Cell Death Differ; 2024 Mar; 31(3):309-321. PubMed ID: 38287116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.
    Yang GD; Huang TJ; Peng LX; Yang CF; Liu RY; Huang HB; Chu QQ; Yang HJ; Huang JL; Zhu ZY; Qian CN; Huang BJ
    PLoS One; 2013; 8(10):e78355. PubMed ID: 24194922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircRNA circTRAF3 promotes nasopharyngeal carcinoma metastasis through targeting miR-203a-3p/AKT3 axis.
    Fang X; Huang W; Wu P; Zeng J; Li X
    Pathol Res Pract; 2021 May; 221():153438. PubMed ID: 33887546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin.
    Zhen Y; Fang W; Zhao M; Luo R; Liu Y; Fu Q; Chen Y; Cheng C; Zhang Y; Liu Z
    Oncogene; 2017 Jan; 36(2):275-285. PubMed ID: 27270423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-302c-5p affects the stemness and cisplatin resistance of nasopharyngeal carcinoma cells by regulating HSP90AA1.
    Zhou X; Zheng L; Zeng C; Wu Y; Tang X; Zhu Y; Tang S
    Anticancer Drugs; 2023 Jan; 34(1):135-143. PubMed ID: 36539366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
    Liu SL; Lin HX; Lin CY; Sun XQ; Ye LP; Qiu F; Wen W; Hua X; Wu XQ; Li J; Song LB; Guo L
    Cancer Lett; 2017 Aug; 402():117-130. PubMed ID: 28583847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.
    Huang PY; Zeng TT; Ban X; Li MQ; Zhang BZ; Zhu YH; Hua WF; Mai HQ; Zhang L; Guan XY; Li Y
    BMC Cancer; 2016 Aug; 16(1):669. PubMed ID: 27549330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/β-catenin signaling pathway.
    Zhang J; Xie T; Zhong X; Jiang HL; Li R; Wang BY; Huang XT; Cen BH; Yuan YW
    Aging (Albany NY); 2020 Mar; 12(6):5423-5438. PubMed ID: 32203052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1.
    Yin P; Song G; Jiang Z
    Cancer Chemother Pharmacol; 2018 May; 81(5):863-872. PubMed ID: 29536130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.